EVEREST ORGANICS
Back to Balance Sheet
|
EVEREST ORGANICS Last 5 Year Net Current Assets History
[Standalone]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Net Current Assets (Including Current Investments) | ₹15 Cr | ₹7.98 Cr | ₹-11 Cr | ₹-5.10 Cr | ₹5.32 Cr |
What is the latest Net Current Assets ratio of EVEREST ORGANICS ?
| Year | Net Current Assets |
|---|---|
| Mar2026 | ₹15 Cr |
| Mar2025 | ₹7.98 Cr |
| Mar2024 | ₹-11 Cr |
| Mar2023 | ₹-5.10 Cr |
| Mar2022 | ₹5.32 Cr |
How is Net Current Assets of EVEREST ORGANICS Trending?
| Years | Net Current Assets | % Change | |
|---|---|---|---|
| Mar2026 | ₹15 Cr | 90.95 | |
| Mar2025 | ₹7.98 Cr | Positive | |
| Mar2024 | ₹-11 Cr | Negative | |
| Mar2023 | ₹-5.10 Cr | Negative | |
| Mar2022 | ₹5.32 Cr | - | |
Compare Net Current Assets of peers of EVEREST ORGANICS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| EVEREST ORGANICS | ₹241.3 Cr | 0.3% | 4.3% | -34.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹452,707.0 Cr | 3.9% | 7.8% | 13% | Stock Analytics | |
| DIVIS LABORATORIES | ₹303,962.0 Cr | 11.5% | 20.6% | 68% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹179,494.0 Cr | 1% | 1.8% | 34.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹115,769.0 Cr | 1.1% | 11.8% | 14.9% | Stock Analytics | |
| CIPLA | ₹113,912.0 Cr | 1.1% | 7.9% | -6.3% | Stock Analytics | |
EVEREST ORGANICS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| EVEREST ORGANICS | 0.3% |
4.3% |
-34.1% |
| SENSEX | 3.3% |
13.9% |
-1.7% |
You may also like the below Video Courses